Bailey Cowan Heckaman, PLLC v. Clark, Love & Hutson, GP

Court of Appeals of Texas·Decided March 27, 2025·No. 11-23-00136-CV·Published

Opinion

Opinion filed March 27, 2025

In The

Eleventh Court of Appeals

No. 11-23-00136-CV

BAILEY COWAN HECKAMAN PLLC, Appellant V.

CLARK, LOVE & HUTSON, GP, Appellee

On Appeal from the 266th District Court Erath County, Texas Trial Court Cause No. CV34950

OPINION This case involves a longstanding and bitter feud between two law firms over splitting the attorneys’ fees generated from large-scale litigation against SmithKline Beecham Corporation d/b/a GlaxoSmithKline (SmithKline). Appellee, Clark, Love & Hutson, GP (Clark), alleged that Appellant, Bailey Cowan Heckaman PLLC (Bailey), failed to honor its obligation to share attorneys’ fees with Clark under a 2007 letter agreement. Bailey, on the other hand, maintained that Clark

withdrew from the agreement in 2010, and that it had no obligation to share fees that were earned after the purported withdrawal.

In this interlocutory appeal, Bailey complains that the trial court abused its discretion when it denied Bailey’s motion to dismiss Clark’s breach-of-contract claim under the Texas Citizens Participation Act (TCPA). See TEX. CIV. PRAC. & REM. CODE ANN. §§ 27.001–.011 (West 2020 & Supp. 2024).1 Bailey also complains that the trial court abused its discretion when it found that Bailey had filed the motion for the sole purpose of delay, awarded $100,000 in attorneys’ fees to Clark, and declined to award Bailey attorneys’ fees, court costs, and sanctions.

We modify the trial court’s order to vacate the award of attorneys’ fees to Clark and affirm the order as modified.

Factual and Procedural Background SmithKline is the manufacturer of Paroxetine (Paxil), an antidepressant medication. After SmithKline began selling Paxil in 1992, several reports of Paxil’s adverse side effects were published, and numerous lawsuits were filed against SmithKline alleging personal injury and wrongful death arising out of the use of Paxil.

On April 4, 2007, Bailey and Clark entered into a letter agreement, which contemplated that the firms would “work together on [a] Paxil ad campaign and litigation.” Pursuant to the terms of the agreement, Bailey was responsible for paying for the costs that were associated with advertising Bailey and Clark’s Paxilrelated legal services to the public. The firms would then share in the responsibilities and costs of all litigation arising out of the agreement on a 50/50 basis.

1 The Texas legislature amended the TCPA effective September 1, 2019. See Act of May 17, 2019, 86th Leg., R.S., ch. 378, §§ 1–9, 12, 2019 Tex. Gen. Laws 684, 684–87 (codified at CIV. PRAC. & REM. § 27.001, .003, .005–.007, .0075, .009–.010). We note that the amendments do not affect our analysis in this case.

After entering into the agreement, the parties proceeded with litigation of several Paxil cases, resulting in a settlement in 2010 that was administered by the 212th District Court in Galveston County.

It appears to be undisputed that, as a part of the 2010 settlement, SmithKline asked both firms to agree that they would not be involved in any Paxil cases going forward. This request was problematic because Texas attorneys are prohibited from “offering or making . . . an agreement in which a restriction on the lawyer’s right to practice is part of the settlement of a suit or controversy.” See TEX. DISCIPLINARY RULES PROF’L CONDUCT R. 5.06(b), reprinted in TEX. GOV’T CODE ANN., tit. 2, subtit. G, app. A (Tex. State Bar R. art. X, § 9).

On April 28, 2010, Clayton Clark, a principal of the Clark firm, sent an e-mail to three representatives of the Bailey firm. Among other things, the e-mail indicated that Clark had communicated with counsel for SmithKline that, following the settlement, both the Clark and Bailey firms were “done on Paxil forever.”

At this point, the parties’ accounts of the facts begin to differ. Bailey maintains that it promptly responded to the e-mail, informing the Clark firm that it would not enter into such an agreement. 2 Thus, according to Bailey, because Clark (and only Clark) committed to refrain from Paxil litigation, the parties thereafter “treated the 2007 Agreement as terminated and no longer in force or effect.”

Clark, on the other hand, maintained that, despite its representation to SmithKline that it would no longer represent Paxil clients, both parties continued to operate under the 2007 agreement following the 2010 settlement. In support of this allegation, Clark points out that it frequently consulted with Bailey about ongoing litigation, and that it was “always available to assist” when Bailey called to request

2 Although representatives of Bailey have testified that Bailey put its objection to the agreement in writing, it does not point to any such communication in its briefing.

consultation and advice. Additionally, in September 2011, the Clark firm transferred $500,000 to the Bailey firm for advertising, which it was obligated to provide under the terms of the 2007 agreement.

There is some evidence that the parties attempted to negotiate a new agreement following the 2010 settlement, although the negotiations were not successful. In April 2011, Clayton Clark wrote Ken Bailey, a principal of the Bailey firm, and submitted a proposal for “Paxil cases which were not included in the first round Paxil settlement.” Bailey responded with a counterproposal on the same day, indicating that “[w]e have much to do together in the future.” However, the parties never reached a new agreement.

The parties agree that, following the 2010 settlement, Bailey settled a number of additional cases, but that it did not share its fees from those cases with Clark. Likewise, they agree that Clark settled a number of cases in or around 2012, and that Clark has thus far failed to share the fees from those cases with Bailey. Bailey argues that, because Clark failed to share any fees in connection with those settlements, Clark “clearly believe[ed] that the 2007 Agreement had terminated.” Clark, on the other hand, indicates that it was prepared to share the fees from the 2012 cases, and that Bailey’s share of the fees associated with those cases have been set aside in Clark’s trust account.

The cases that were settled by Bailey were resolved under two master settlement agreements in 2017. Pursuant to the terms of the settlement agreements, two judicial proceedings were filed in a Hardin County District Court for the purpose of creating and administering a settlement trust fund. The record indicates that none of the 605 litigants who participated in the 2017 settlement had consented in writing to the terms of the fee-sharing agreement set out in the 2007 letter agreement.

The lawsuit that is the subject of this appeal was filed by Clark in April 2018.

In its initial pleading, Clark alleged that it was “entitled to one-half of attorneys’ fees” from the 2017 settlements and sought “an accounting of all past and pending settlements from the Paxil litigation in which the Bailey Law Firm has served as lead counsel or as a primary counsel.” Thereafter, Clark filed four amended petitions, each of which sought a declaratory judgment relating to Clark’s rights under the 2007 letter agreement.

On February 3, 2023, the trial court set the case for a bench trial that was to take place on April 5, 2023. Ten days later, Clark filed a fifth amended petition, asserting—for the first time—a cause of action for breach of contract. On February 22, 2023, Bailey filed an amended answer to Clark’s petition that included a demand for a jury trial. Bailey tendered a jury fee the next day. On February 27, Clark filed a sixth amended petition, which again asserted a cause of action for breach of contract. Thereafter, on March 28, 2023, the trial court sent a letter to the parties setting the case for a jury trial on July 10, 2023.

Free access — add to your briefcase to read the full text and ask questions with AI

Bailey Cowan Heckaman, PLLC v. Clark, Love & Hutson, GP, (Tex. Ct. App. 2025).

Bailey Cowan Heckaman, PLLC v. Clark, Love & Hutson, GP (Bailey Cowan Heckaman, PLLC v. Clark, Love & Hutson, GP) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

TGS-NOPEC GEOPHYSICAL CO. v. Combs
340 S.W.3d 432 (Texas Supreme Court, 2011)
Wichita County v. Bonnin
268 S.W.3d 811 (Court of Appeals of Texas, 2008)
Johnson v. Brewer & Pritchard, P.C.
73 S.W.3d 193 (Texas Supreme Court, 2002)
Kirkstall Road Enterprises, Inc. v. Arking Jones
523 S.W.3d 251 (Court of Appeals of Texas, 2017)
John David Adams v. Starside Custom Builders, Llc
547 S.W.3d 890 (Texas Supreme Court, 2018)
Mark Silguero and Amy Wolfe v. Csl Plasma, Incorporated
579 S.W.3d 53 (Texas Supreme Court, 2019)
In the Interest of M.N.
262 S.W.3d 799 (Texas Supreme Court, 2008)
Sullivan v. Tex. Ethics Comm'n
551 S.W.3d 848 (Court of Appeals of Texas, 2018)